A 22-year-old woman, known case of autoimmune hepatitis, underwent liver transplantation. She discharged from the hospital in good condition. After 50 days, she presented with abnormal liver enzyme (ALT=117 IU/L, AST=167 IU/L). Laboratory investigation showed positive IgM anti-CMV antibody. Anti-VCA (EBV) IgM was negative. Liver biopsy was performed ([Fig 1](#F1){ref-type="fig"}). All the bacterial and fungal cultures were negative.

WHAT IS YOUR DIAGNOSIS?
=======================

**Diagnosis**: Post-Liver Transplantation Cytomegalovirus Hepatitis

The differential diagnosis of liver dysfunction after orthotopic liver transplantation can be challenging. Cytomegalovirus (CMV) hepatitis is one possibility \[[@B1]\]. It is not common and occurs in 2.4% of liver transplant patients \[[@B2]\]. The incidence of CMV infection after liver transplantation depends on several factors including the available diagnostic tools, donor and recipient sero-status, the peri-operative prophylaxis, and anti-rejection and immunosuppressive regimen used \[[@B3]\].

Diagnosis of CMV hepatitis after liver transplantation can be made by measuring IgM anti-CMV antibody, molecular methods such as real-time PCR, virus culture and liver biopsy. Liver biopsy is the gold-standard test for the diagnosis CMV hepatitis. The diagnosis is made by detecting viral CMV inclusion bodies in H&E and immunohistochemical stating ([Fig 2](#F2){ref-type="fig"}).

![Sections from transplanted liver needle biopsy 50 days after the transplantation. a) Low magnification (×100), b) high magnification (×400) H&E staining](ijotm-6-091-g001){#F1}

![Immunohistochemical staining of sections from the liver needle biopsy showing CMV inclusion bodies](ijotm-6-091-g002){#F2}
